The Psychedelic Revolution

Motley Fool Hidden Gems Investing

The Motley Fool

Investing, Business

4.3 • 3.1K Ratings

🗓️ 12 April 2026

⏱️ 24 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

What if the next big breakthrough in mental health care has nothing to do with taking a daily pill? Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, join the show to discuss their new book, Psychedelic Therapy: A Revolutionary Approach to Restoring Mental Health and Reclaiming Your Life. Motley Fool analyst Sanmeet Deo talks with the founders about the shift from a counterculture fringe movement to an FDA-backed clinical model, Big Pharma's strategy, and why the real investing opportunity lies in a $20,000 service. Host: Sanmeet Deo Guest: Will Van Derveer, Keith Kurlander Producer: Bart Shannon, Mac Greer Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement.We’re committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode.Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	So that landscape is different in terms of what you're investing in.
0:08.0	You're not investing in a drug that people are going to be taking every day of their life.
0:12.0	You're investing in a drug that will hopefully help somebody get on stock from resistant forms of mental health conditions
0:20.0	and then get to start moving on with their life.
0:25.9	That was Keith Curlander, co-author of the new book, Psychedelic Therapy,
0:34.7	a revolutionary approach to restoring mental health and reclaiming your life.
0:39.6	I'm Motley Fool, producer, Matt Greer.
0:41.9	Motley Fool analyst San Mate Dale recently talked with Carlander and co-author Dr. Will Vandervere
0:47.7	about that psychedelic revolution and the investing opportunities ahead. Enjoy.
0:54.4	Hey, fools. Today we're zooming out to look at a massive paradigm shift happening in the health
0:59.5	sector, one that has profound implication for a culture, a well-being, and the broader economic
1:04.1	landscape. So for decades, traditional mental health systems relied heavily on managing
1:08.5	symptoms. But there's a growing movement backed by serious
1:12.2	clinical research and FDA trials pointing toward a totally different model. It's moving fast. Just
1:17.6	recently, Compass Pathways, which is publicly traded, tickers CMPS, saw it stocked up over 23%
1:23.8	after announcing that it's phase three trials for COMP 360, the silocybin treatment, demonstrate
1:29.7	a well-tolerated safety profile, and now they're getting up for the FDA.
1:33.7	So as psychedelic stocks rise on the news, my guest today argue that it's not a hype trade,
1:37.9	but rather the kind of the birth of a brand new healthcare category.
1:41.0	So today I have Dr. Will van der Veer and Keith Carlander, founders of the Integrative Psychiatry Institute and authors of the new book, Psychedelic Therapy, a revolutionary approach to restoring mental health and recovering your life. Well, Keith, welcome to the show. Thanks. Good to be here. Great to be with you. Let's start right at the foundation. You know, you argue at the recent surge in stocks like Compass Pathways. This isn't just a hype trade, but the birth of a brand new health care category.
2:03.5	So what belief about psychedelic therapy to most people and most investors get completely wrong?
2:09.8	And why does this misunderstands matter?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.